Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve unaudited financial results for quarter and half year ended September 30, 2026.

October 29, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, Dalal Street, Fort, G Block, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai 400 051 Scrip Code: 506414 Trading Symbol: FERMENTA Dear Sir, Sub: Notice of the Board Meeting Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, November 5, 2026, inter alia, to consider and approve the unaudited financial results of the Company (standalone and consolidated) for the quarter and half year ended September 30, 2026. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders, in terms of BSE Circular LIST/COMP/01/2019-20 dated April 2, 2019 and the Company’s intimation (to BSE Limited) regarding closure of trading window vide letter dated September 29, 2026, the “Trading Window" period (for trading in Company’s securities) has been closed with effect from October 1, 2026 and shall continue to remain closed till 48 hours after the declaration of unaudited financial results pursuant to the Board meeting to be held on November 5, 2026. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons and their immediate relatives and also Auditors and other Connected Persons shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company’s Equity Shares, either in their own name or in the name of their immediate relatives. Terms not defined in this notice shall have the same meaning as defined in the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders. This is for your information and record. Thanking you, Yours faithfully, For Fermenta Biotech Limited Varadvinayak Khambete Company Secretary & Head - Legal Membership No. A33861